%0 Journal Article
%T Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
%A Bruna Scaggiante
%A Daniele Generali
%A Fabrizio Zanconati
%A Marina Bortul
%A Navid Sobhani
%J Archive of "World Journal of Clinical Oncology".
%D 2018
%R 10.5306/wjco.v9.i8.172
%K Hormone receptor positive/Her2-negative breast cancer
%K PI3K
%K mTOR
%K TORC1/2
%K Akt
%K Everolimus
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314865/